Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionVirtus ETF Advisers LLC
Latest Disclosed Ownership625 shares
Latest Disclosed Value $ 219,906
Virtus ETF Advisers LLC reports 19.35% decrease in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Virtus ETF Advisers LLC filed a 13F-HR form disclosing ownership of 625 shares of Amgen Inc. (CH:AMGN) valued at $219,906 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 775 shares of Amgen Inc.. This represents a change in shares of -19.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 625 -150 -19.35 220 -13.44 0.0623
2026-02-13 2025-12-31 13F AMGEN COM 031162100 775 234 43.25 254 66.45 0.1199
2026-02-13 2025-09-30 13F/A-1 AMGEN COM 031162100 541 541 153 0.0841
2026-02-13 2025-03-31 13F/A-1 AMGEN COM 031162100 0 -1,276 -100.00 0 -100.00
2025-05-14 2025-03-31 13F AMGEN COM 031162100 0 0
2025-02-14 2024-12-31 13F AMGEN COM 031162100 1,276 173 15.68 333 -6.48 0.1358
2024-11-14 2024-09-30 13F AMGEN COM 031162100 1,103 0 0.00 355 3.20 0.1662
2024-08-14 2024-06-30 13F AMGEN COM 031162100 1,103 -278 -20.13 345 -12.24 0.1688
2024-05-15 2024-03-31 13F AMGEN COM 031162100 1,381 200 16.93 393 15.29 0.2086
2024-02-15 2023-12-31 13F AMGEN COM 031162100 1,181 -198 -14.36 340 -8.11 0.2159
2023-11-07 2023-09-30 13F AMGEN COM 031162100 1,379 -167 -10.80 371 7.87 0.2251
2023-08-14 2023-06-30 13F AMGEN COM 031162100 1,546 398 34.67 343 23.83 0.2034
2023-05-15 2023-03-31 13F AMGEN COM 031162100 1,148 32 2.87 278 -5.46 0.1527
2023-02-14 2022-12-31 13F AMGEN COM 031162100 1,116 115 11.49 293 29.65 0.1531
2022-11-14 2022-09-30 13F AMGEN COM 031162100 1,001 16 1.62 226 -5.83 0.0901
2022-08-12 2022-06-30 13F AMGEN COM 031162100 985 -755 -43.39 240 -42.99 0.0890
2022-05-16 2022-03-31 13F AMGEN COM 031162100 1,740 0 0.00 421 7.67 0.1884
2022-02-14 2021-12-31 13F AMGEN COM 031162100 1,740 -151 -7.99 391 -2.74 0.1477
2021-11-15 2021-09-30 13F AMGEN COM 031162100 1,891 -179 -8.65 402 -20.40 0.1769
2021-08-10 2021-06-30 13F AMGEN COM 031162100 2,070 -680 -24.73 505 -26.17 0.2076
2021-05-17 2021-03-31 13F AMGEN COM 031162100 2,750 98 3.70 684 12.13 0.2889
2021-02-12 2020-12-31 13F AMGEN COM 031162100 2,652 -31 -1.16 610 -10.56 0.2532
2020-11-13 2020-09-30 13F AMGEN COM 031162100 2,683 227 9.24 682 17.79 0.3577
2020-08-05 2020-06-30 13F AMGEN COM 031162100 2,456 -33 -1.33 579 14.65 0.2742
2020-05-14 2020-03-31 13F AMGEN COM 031162100 2,489 -210 -7.78 505 -22.43 0.2078
2020-02-13 2019-12-31 13F AMGEN COM 031162100 2,699 -1,240 -31.48 651 -14.57 0.1064
2019-11-12 2019-09-30 13F AMGEN COM 031162100 3,939 -658 -14.31 762 -10.04 0.1535
2019-08-13 2019-06-30 13F AMGEN COM 031162100 4,597 4,597 847 0.1786
2017-02-14 2016-12-31 13F AMGEN COM 031162100 0 -4,071 -100.00 0 -100.00
2016-11-14 2016-09-30 13F AMGEN COM 031162100 4,071 514 14.45 679 25.51 0.3283
2016-08-15 2016-06-30 13F AMGEN COM 031162100 3,557 -87 -2.39 541 -0.92 0.4015
2016-05-16 2016-03-31 13F AMGEN COM 031162100 3,644 0 0.00 546 -7.77 0.7522
2016-02-16 2015-12-31 13F AMGEN COM 031162100 3,644 3,644 592 1.6249
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.